WBEN Photo

Reports: Rep. Chris Collins under scrutiny in probe

Collins denies any wrongdoing

May 17, 2017 - 5:59 am

Buffalo, N.Y. (WBEN) - Multiple reports indicate Western New York Republican Congressman Chris Collins is the subject of a Capitol Hill ethics probe.  The Buffalo News and WGRZ say Collins' actions involving an Austrailian biotech firm, Innate Immunotherapeutics, are the subject of a probe by the Congressional Ethics Office.

The investigation into Collins' stock purchases in the company are said to be moving quickly and are in the fact-gathering and review mode at this point.

Collins' office isn't denying the investigation but is denying any wrongdoing on the part of the Congressman, saying:

“Despite the continued partisan attacks insinuating otherwise, Congressman Collins has followed all ethical guidelines related to his personal finances during his time in the House and will continue to do so."  

“Congressman Collins’ relationship with Innate Immunotherapeutics dates back more than 15 years. Secondary Progressive Multiple Sclerosis is one of the most debilitating diseases in the world and Congressman Collins saw its deadly impact first hand as it affected a close family member. As of now, it has no cure and no relief of symptoms. He is very proud of the progress the company has made over the years and hopeful it will develop a potentially life-saving treatment for the millions of individuals suffering from Secondary Progressive Multiple Sclerosis.”

Comments ()